Dattatreyudu Nori   Professor of Clinical Radiation Oncology

Phone
  • (212) 746-3679 (Office)

Co-Investigator, National Cancer Institute Contract on Three Dimensional External Treatment Planning, Contract #: NCI-C11-37616-2, 1989. Principal Investigator (Clinical), National Cancer Institute Contract on Brachytherapy, Contract #: NCI-CM57776, 1989. Principal Investigator, FDA approved, GAMMA-TWO Multi-institutional Registry Study of Intracoronary Brachytherapy To Prevent Post-Angioplasty In-stent Restenosis, 1999. Principal Investigator, FDA approved, Stents and Radiation Trial (START), Multi-institutional Randomized Phase III Trial of Intracoronary Brachytherapy Using the Novoste Device in Patient With In-stent Restenosis, 1999. Principal Investigator, FDA approved, GAMMA-ONE, International Multi-institutional Randomized Phase III Study of Intracoronary Brachytherapy to Prevent Post-angioplasty Restenosis, 1999. Principal Investigator, FDA approved Beta-Cath Study, Multi-institutional Randomized Phase III Trail of Intracoronary Brachytherapy Using The Novoste Device to Prevent Post-angioplasty Restenosis, 1999. Principal Investigator, FDA approved, Peripheral Artery Radiation Investigational Study (PARIS), Multi-institutional Randomized Phase III Trial of Post-angioplasty Endovascular Brachytherapy Using a High Dose Rate Remote Afterloader to Prevent Post-angioplasty Restenosis, 1999. Principal Investigator, FDA approved IDE for a Phase I/II Study of Post-angioplasty External Beam Radiotherapy (Using Electrons) for Compromised Dialysis Accesses, 1999. Principal Investigator, New York Hospital Medical Center of Queens, Phase I/II Study of Endovascular High Dose Rate Brachytherapy Following Angioplasty for Failing Arteriovenous Dialysis Fistulas, 1999. Principal Investigator, New York Cancer Project, The New York Hospital Medical Center of Queens, funded by AMDeC, a private organization sponsored by all the academic medical centers in New York, 2000. Co-Investigator on 15 additional Radiation, Surgical and Medical Oncology IRB approved protocols, 2004.

Publications

Sort by

Selected publications

Background

Primary Affiliation

  • Weill Cornell Medical College, Cornell University

Contact

full name

  • Dr. Dattatreyudu Nori

primary email

  • dnori@med.cornell.edu